Vaagn Andikyan, MD

Dr. Vaagn Andikyan is a highly skilled gynecologic oncologist who recently joined the University of South Florida and Tampa General Hospital from Yale University. With expertise in minimally invasive and robotic surgery, Dr. Andikyan has made significant contributions to improving surgical outcomes and advancing patient care. As the Director of the Hyperthermic Intraperitoneal Chemotherapy (HIPEC) program, he has pioneered innovative treatments for ovarian cancer, improving survival rates and improving perioperative outcomes. In addition, Dr. Andikyan has played a key role in the implementation of Enhanced Recovery After Surgery (ERAS) protocols, significantly optimizing patients' quality of life and their experiences.





Dr. Andikyan is actively involved in research focused on improving surgical metrics, targeted therapies in gynecologic oncology, and addressing financial toxicity in cancer care. His work has been published in esteemed journals, contributing to advancements in the field of gynecologic oncology. He has also received numerous awards and is widely recognized for performing a life-saving surgery to remove a 132-pound ovarian tumor.





Through leadership roles in organizations such as the Society of Gynecologic Oncology and the American Society of Clinical Oncology, Dr. Andikyan continues to advocate for equitable access to high-quality healthcare and the advancement of women's health. His patient-centered approach, combined with his expertise and passion for innovation, defines his commitment to improving outcomes and transforming lives. Dr. Andikyan is fluent in English, Russian and Armenian.